Auna SA Hits 52-Week Low, Trading at USD 4.16 Amid Decline

Auna SA, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reached a new 52-week low, trading at USD 4.16 on May 26, 2026. This decline marks a significant downturn for the stock, which has seen a one-year performance of -32.03%, contrasting sharply with the S&P 500's performance of 29.58% over the same period. The company's market capitalization stands at USD 383 million, and it currently has a price-to-earnings (P/E) ratio of 7.00. Auna SA's price-to-book ratio is 0.80, indicating a valuation that may reflect investor sentiment regarding its financial health. Notably, the company has reported a return on equity of -999,999.00%, which raises concerns about its profitability and operational efficiency. Despite achieving positive results earlier in the year, Auna SA's performance has been below par both in the short and long term. The stock's previous 52-week high was USD 6.97, highlighting the extent of its recent decline. As the company navigates these challenges, its financial metrics will be closely monitored by market participants.